Immunovant, Inc.IMVTNASDAQ
Loading
Income Tax Expense Over TimeExpanding
Percentile Rank100
3Y CAGR+639.7%
Studio
Year-over-Year Change

Income taxes paid or accrued

3Y CAGR
+639.7%/yr
Annual compound
Percentile
P100
Near historical high
vs 3Y Ago
404.7x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
PeriodValueYoY Change
TTM$3.64M+308.8%
2025$891000.00+57.1%
2024$567000.00+6200.0%
2023$9000.00+110.7%
2022$-84000.00+76.5%
2021$-358000.00-469.1%
2020$97000.00-
2019$0.00-
2018$0.00-